Quoin Pharmaceuticals News

Quoin Pharmaceuticals | 8-K: Current report

Apr 10 04:11

Quoin Pharmaceuticals | EFFECT: Others

Apr 4 18:05

Quoin Pharmaceuticals | DEFA14A: Others

Apr 2 23:09

Quoin Pharmaceuticals | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

Mar 30 04:15

Quoin Pharmaceuticals | 10-K: Annual report

Mar 15 04:46

Quoin Pharmaceuticals | 8-K: Quoin Pharmaceuticals Provides Corporate Update and Announces Fourth Quarter and 2023 Financial Results

Mar 14 04:56

Quoin Pharmaceuticals | 424B3: Prospectus

Mar 9 05:13

Quoin Pharmaceuticals | 8-K: Current report

Mar 9 05:08

Quoin Pharmaceuticals | 424B3: Prospectus

Mar 9 05:06

Quoin Pharmaceuticals | 424B4: Prospectus

Mar 7 06:11

Quoin Pharmaceuticals | 8-K: Current report

Mar 7 05:06

Quoin Pharmaceuticals | 424B3: Prospectus

Mar 5 06:34

Quoin Pharmaceuticals | DEF 14A: Definitive information statements

Feb 27 19:11

Quoin Pharmaceuticals | EFFECT: Others

Feb 15 19:12

Quoin Pharmaceuticals | CORRESP: CORRESP

Feb 15 01:36

Quoin Pharmaceuticals | CORRESP: CORRESP

Feb 15 01:36

Quoin Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lind Global Fund II LP(6.0%),Lind Global Partners II LLC(6.0%), etc.

Feb 14 09:16

Quoin Pharmaceuticals | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Feb 14 05:55

Quoin Pharmaceuticals | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Feb 14 05:39

Quoin Pharmaceuticals | UPLOAD: Others

Feb 14 01:36